Renal Diseases Market Reports Empesis on Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

The Frontier Pharma: Renal Diseases High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease assesses first-in-class innovation in the renal diseases pipeline, highlighting key trends and emerging treatment classes.

Pune, India - March 14, 2018 /MarketersMedia/ —

The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the increased prevalence of hypertension and diabetes, two major causes of CKD. For most forms of renal diseases, early detection and management may slow down or prevent progression to renal failure and associated complications. However, many renal diseases are typically asymptomatic until they have progressed to end-stage renal disease (ESRD), which requires renal replacement therapies such as hemodialysis and renal transplantation, and is associated with substantial morbidity and mortality.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease

The first-in-class programs identified show considerable diversity, and the relatively high degree of innovation in the renal diseases therapy area makes for a promising development pipeline. It is clear that recent activity in this area has increased, partly owing to the growing recognition of the unmet medical need. Further investment in innovation would benefit the therapy area greatly, and likely prove a worthwhile investment, particularly for highly prevalent diseases such as CKD and diabetic nephropathy, for which there are a lack of effective pharmacotherapeutic options.

Get this report at: https://www.themarketreports.com/report/buy-now/935551

Scope
• With 365 products in active development, the pipeline is modestly sized. Does current pipeline innovation hold the potential to affect the future renal diseases market?
• There are 100 first-in-class products in the renal diseases pipeline. Which of these hold the greatest potential to improve future disease treatment with regard to their molecular target?
• The majority of first-in-class products were in development for indications involving inflammation. Which first-in-class targets are most promising, and how does the ratio of first-in-class targets to first-in-class products differ by stage of development and molecular target class?
• A significant number of first-in-class products have been identified with no prior involvement in deals. How do deal frequency and value compare between target families and molecule types, and which first-in-class programs have not yet been involved in a licensing or co-development deal?

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935551

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/renal-diseases-market-reports-empesis-on-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease/314328

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease%20%20

Source: MarketersMedia

Release ID: 314328

Latest News

Big Five? Talent-rich Celtics embracing lofty expectations

Sep 25, 2018

CANTON, Mass. — Last summer, new Boston Celtics arrivals Kyrie Irving and Gordon Hayward beamed just imagining what it would be like to share the court together. Those dreams lasted all of five minutes before Hayward was lost for the season to a gruesome leg injury on the opening night of the season. The Celtics somehow survived it and had set themselves up to make a run at the Eastern Conference title when Irving was lost for the final stretch of the regular season and the playoffs following a pair of knee surgeries. But four months after a season with...

No LeBron, no spotlight: Cavaliers start anew without star

Sep 25, 2018

INDEPENDENCE, Ohio — As the Cavaliers wandered around posing for silly photographs, reading radio promotions and doing interviews, everything felt different. This media day was nothing like the past four. Cleveland heads into the season with very little buzz, zero drama and low expectations. The spotlight, which has illuminated the Cavs in recent years, is pointed elsewhere. LeBron James left and it all went with him. "I'm still here," coach Tyronn Lue said, laughing. The Cavs began life without James in earnest on Monday, taking their first steps since the superstar signed with the Los Angeles Lakers this summer and...

With new coach and new arena, Giannis, Bucks are all smiles

Sep 25, 2018

MILWAUKEE — Giannis Antetokounmpo was all smiles but had no jokes. The Milwaukee Bucks' All-Star forward was more business this time around: While he didn't indulge reporters by opening his media day session on Monday with a gag, as he had done in previous years, Antetokounmpo still flashed an infectious grin. Things are looking up for the Milwaukee Bucks as they move into a new arena this fall, with a new coach leading a team headlined by one of the NBA's bright, young stars. The organization once had billboards around the city that read "Own the Future." That future is...

The Latest: Cosby lawyer argues to keep him out of prison

Sep 25, 2018

NORRISTOWN, Pa. — The Latest on Bill Cosby's sentencing hearing (all times local): 3:45 p.m. Bill Cosby's lawyer says the 81-year-old comedian is a poor candidate for prison because he's old, legally blind and dependent on others. Defense lawyer Joseph Green argued at Cosby's sentencing hearing Monday that Cosby would be at risk behind bars. He called prison an "excessive hardship." Green suggested an alternative punishment program would be more appropriate. Court has adjourned for the day. A judge is expected to sentence Cosby on Tuesday. Cosby's lawyer says a psychologist set to testify Tuesday will be the only defense...

Porzingis rehabbing conservatively, unsure when he'll return

Sep 25, 2018

GREENBURGH, N.Y. — Kristaps Porzingis is a one-of-a-kind player, a 7-foot-3 package strong enough to pound in the paint but with plenty of speed and shooting to play on the perimeter. That's ideal for the basketball court. Not so much for rehabbing a serious knee injury. Porzingis said Monday his size has necessitated a slow recovery from a torn left ACL and prevents him or the New York Knicks from establishing a timetable for his return to action. "We've done things differently because there is no protocol for a 7-3 guy," Porzingis said. "There is no timetable for my type...

About Us

The Final Scoreboard has fast, accurate live scores for you. We provide premium online content from in-depth analysis to the scores and statistics across American and European Sports.

Contact us: sales[at]thefinalscoreboard.com

Subscribe Now!